Abstract:The sugar boronated thymidine nucleoside, 5' -0-[(triphenylphosphine-boryl) carbonyl]-3'-0-acetyl thymidine 1, and the boron-modified nucleoside phosphotriester, 5'-(diethylphosphite- cyanoborane)-3'-acetylthymidine 2, were successfully synthesized. Both compounds demonstrated differential activity when tested against eight cell lines, with significant cytotoxic activity against the growth of human Tmolt3 leukemia, colon adenocarcinoma, HeLa S3 uterine carcinoma, and osteosarcoma cells. In in vivo studies these agents were found to be active against the growth of Ehrlich ascites carcinoma at 8 mg/kg/day I.P. and to be marginally active against the growth of L1210 and Lewis lung cancers in mice. The mode of action of these thymidine derivatives in Tmolt3 cells was the inhibition of DNA and protein synthesis. Compound 2 was highly effective in inhibiting DNA polymerase alpha and m-RNA, r-RNA and t-RNA polymerase activities. Both compounds inhibited ribonucleoside reductase activity. The de novo purine pathway appeared to be the major site of inhibition of the agents, with IMP dehydrogenase, PRPP amido transferase, and dihydrofolate reductase activities being significantly inhibited. In the pyrimidine pathway, carbamyl phosphate synthetase and aspartate transcarbamylase activities were inhibited by 1. As expected, d[NTP] levels were significantly reduced by treatment with the agents. DNA strand scission was evident after incubating Tmolt3 cells for 24 hr with the agents.

Synthesis of new classes of boron-containing nucleotides

Synthesis of Boron-Containing Nucleoside Analogs

Synthesis of Alpha-P-modified Nucleoside Diphosphates with Ethylenediamine.

Synthesis, reactivity and biological activity of N(4)-boronated derivatives of 2'-deoxycytidine

Design, synthesis, and polymerase-catalyzed incorporation of click-modified boronic acid-TTP analogues

Triphenyl Borates used to Avoid the Bay-Position Halogenation of Boron Subnaphthalocyanines; and for the Subnaphthalocyanine, Subphthalocyanine and Hybrids Formation.

Synthesis and in vitro evaluation of boronated uridine and glucose derivatives for boron neutron capture therapy

Boronated thymidine analogues for boron neutron capture therapy

Synthesis of 5 '-Thio-3 '-O-ribonucleoside Phosphoramidites

Synthesis of Pyridiniumboranephosphonate Diesters and Related Compounds using Trityl Cation as a Borane Hydride Acceptor

Synthesis and biological evaluation of boronated nucleosides for boron neutron capture therapy (BNCT) of cancer

Synthesis of 4'-Thionucleoside Analogues Bearing a C2' Stereogenic All-Carbon Quaternary Center

Anomeric sugar boronic acid analogues as potential agents for boron neutron capture therapy

Antineoplastic activity of boron-containing thymidine nucleosides in Tmolt3 leukemic cells

Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy

New Boron Containing Acridines: Synthesis and Preliminary Biological Study

Synthesis and novel properties of alkyl thiophosphoramidate derivatives of nucleosides

Biological activity of N(4)-boronated derivatives of 2'-deoxycytidine, potential agents for boron-neutron capture therapy

Boron-containing protoporphyrin IX derivatives and their modification for boron neutron capture therapy: synthesis, characterization, and comparative in vitro toxicity evaluation

Labeled Undecahydro-closo-dodecaborates Based on Azo Dyes for Boron Neutron Capture Therapy: Synthesis, Characterization, and Visualization in Cells

Synthesis of AZT/d4T Boranophosphates as Anti-HIV Prodrug Candidates